Nanjing Vazyme Biotech Co., Ltd.
SSE:688105.SS
22.71 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 284.655 | 391.987 | 336.639 | 343.611 | 299.501 | 417.435 | 298.258 | 268.843 | 302.194 | 1,263.976 | 685.295 | 644.375 | 975.338 | 579.997 | 463.07 | 283.921 | 541.64 | 426.203 | 344.791 | 586.195 | 207.265 |
| Cost of Revenue
| 87.19 | 123.331 | 101.08 | 126.712 | 87.256 | 142.413 | 94.447 | 63.572 | 94.676 | 484.389 | 207.101 | 172.934 | 246.087 | 179.582 | 62.426 | 67.911 | 40.929 | 43.133 | 38.77 | 39.891 | 11.838 |
| Gross Profit
| 197.465 | 268.656 | 235.559 | 216.9 | 212.246 | 275.022 | 203.811 | 205.271 | 207.519 | 779.587 | 478.194 | 471.442 | 729.251 | 400.415 | 400.644 | 216.009 | 500.711 | 383.07 | 306.02 | 546.304 | 195.428 |
| Gross Profit Ratio
| 0.694 | 0.685 | 0.7 | 0.631 | 0.709 | 0.659 | 0.683 | 0.764 | 0.687 | 0.617 | 0.698 | 0.732 | 0.748 | 0.69 | 0.865 | 0.761 | 0.924 | 0.899 | 0.888 | 0.932 | 0.943 |
| Reseach & Development Expenses
| 66.469 | 76.594 | 72.022 | 61.123 | 70.763 | 81.768 | 74.49 | 86.979 | 84.908 | 126.211 | 112.925 | 85.814 | 71.157 | 82.458 | 63.347 | 46.326 | 38.192 | 40.179 | 38.224 | 0 | 0 |
| General & Administrative Expenses
| 0 | -103.491 | 137.939 | -29.387 | 53.875 | -117.127 | 140.952 | -34.248 | 66.293 | -75.985 | 134.818 | -2.781 | 49.079 | -30.909 | 78.439 | 45.637 | 23.766 | -8.664 | 36.493 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | -150.928 | 251.833 | 114.628 | 103.028 | 143.191 | 102.415 | 123.904 | 103.177 | 176.925 | 141.949 | 113.61 | 89.918 | 117.979 | 97.888 | 55.794 | 47.806 | 60.759 | 45.545 | 0 | 0 |
| SG&A
| 157.246 | -254.419 | 389.772 | 162.411 | 158.54 | 210.639 | 243.367 | 89.656 | 169.47 | 100.94 | 276.767 | 110.829 | 138.997 | 87.07 | 176.326 | 101.624 | 74.447 | 52.095 | 82.038 | 0 | 0 |
| Other Expenses
| -20.578 | 487.388 | -6.428 | -3.091 | -8.702 | -59.915 | -10.828 | 1.036 | -13.157 | 195.736 | -63.921 | 65.55 | 0.498 | -4.5 | -2.708 | -159.412 | -109.164 | -3.162 | 0.015 | -139.372 | -60.168 |
| Operating Expenses
| 203.136 | 318.856 | 243.703 | 226.624 | 238.005 | 352.322 | 210.182 | 261.897 | 241.22 | 422.887 | 325.771 | 262.193 | 210.652 | 253.785 | 210.032 | -159.412 | -109.164 | 132.778 | 107.713 | -139.372 | -60.168 |
| Operating Income
| -5.345 | -50.2 | -8.144 | -9.724 | -25.76 | -77.3 | 9.534 | -40.003 | -33.702 | -129 | 143.395 | 197.964 | 505.135 | 145.429 | 177.563 | 56.598 | 391.548 | 247.314 | 183.511 | 406.932 | 135.26 |
| Operating Income Ratio
| -0.019 | -0.128 | -0.024 | -0.028 | -0.086 | -0.185 | 0.032 | -0.149 | -0.112 | -0.102 | 0.209 | 0.307 | 0.518 | 0.251 | 0.383 | 0.199 | 0.723 | 0.58 | 0.532 | 0.694 | 0.653 |
| Total Other Income Expenses Net
| 1.074 | 0.168 | 0.155 | 11.859 | 3.44 | 69.833 | -10.828 | 1.036 | -1.163 | -108.124 | 0.433 | 0.137 | -0.045 | -4.5 | -1.865 | -0.046 | -0.282 | -3.162 | 0.015 | -7.758 | -2.853 |
| Income Before Tax
| -4.271 | -50.033 | -7.989 | 2.135 | -2.365 | -7.467 | -1.293 | -38.966 | -67.988 | -237.124 | 143.323 | 198.101 | 505.089 | 140.929 | 175.699 | 56.552 | 391.266 | 244.152 | 183.525 | 399.174 | 132.407 |
| Income Before Tax Ratio
| -0.015 | -0.128 | -0.024 | 0.006 | -0.008 | -0.018 | -0.004 | -0.145 | -0.225 | -0.188 | 0.209 | 0.307 | 0.518 | 0.243 | 0.379 | 0.199 | 0.722 | 0.573 | 0.532 | 0.681 | 0.639 |
| Income Tax Expense
| -6.128 | -13.398 | -9.695 | -8.295 | -7.24 | -12.321 | -5.566 | -8.186 | -16.779 | -81.133 | 7.767 | 15.519 | 73.73 | 12.856 | 17.34 | 99.344 | -54.412 | 27.51 | 31.423 | 88.379 | -41.69 |
| Net Income
| 1.91 | -36.25 | 1.997 | 10.943 | 5.216 | 5.433 | 4.704 | -30.47 | -51.209 | -155.991 | 135.794 | 182.582 | 431.359 | 128.072 | 158.359 | 55.344 | 336.514 | 216.642 | 152.102 | 339.051 | 113.93 |
| Net Income Ratio
| 0.007 | -0.092 | 0.006 | 0.032 | 0.017 | 0.013 | 0.016 | -0.113 | -0.169 | -0.123 | 0.198 | 0.283 | 0.442 | 0.221 | 0.342 | 0.195 | 0.621 | 0.508 | 0.441 | 0.578 | 0.55 |
| EPS
| 0.005 | -0.092 | 0.005 | 0.028 | 0.013 | 0.014 | 0.012 | -0.076 | -0.13 | -0.39 | 0.34 | 0.46 | 1.08 | 0.32 | 0.4 | 0.14 | 0.93 | 0.54 | 0.38 | 0.85 | 0.28 |
| EPS Diluted
| 0.005 | -0.092 | 0.005 | 0.028 | 0.013 | 0.013 | 0.012 | -0.076 | -0.13 | -0.39 | 0.34 | 0.46 | 1.08 | 0.32 | 0.4 | 0.14 | 0.93 | 0.54 | 0.38 | 0.85 | 0.28 |
| EBITDA
| 2.72 | 7.098 | -0.987 | 62.042 | 6.598 | -21.507 | 66.765 | 33.276 | -28.544 | -158.165 | 220.71 | 234.831 | 543.57 | 168.621 | 201.838 | 73.905 | 391.649 | 243.755 | 199.519 | 337.236 | 195.428 |
| EBITDA Ratio
| 0.01 | 0.018 | -0.003 | 0.181 | 0.022 | -0.052 | 0.224 | 0.124 | -0.094 | -0.125 | 0.322 | 0.364 | 0.557 | 0.291 | 0.436 | 0.26 | 0.723 | 0.572 | 0.579 | 0.575 | 0.943 |